| Name | Title | Contact Details |
|---|
Watercrest Senior Living Group specializes in the development and operations of assisted living and memory care communities, market repositioning and advisory services. The principals have an impressive track record of leading the turnaround of underperforming assets and the stabilization of newly built communities. Partnering with a wide variety of stakeholders such as land owners, real estate developers, investors, financial institutions, and REITs, Watercrest Senior Living Group focuses on its core strengths, operations management of assisted living and memory care communities and the development of servant leaders. With state of the art information systems and key vendor partnerships, we are well positioned to efficiently assimilate both existing assisted living and memory care communities and the next generation of senior living product.
Biodenix Technologies Inc. is a Richmond, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Civitas Senior Living is a team of senior living experts that provide all facets of senior living operations. This expertise includes extensive experience in Assisted Living, Memory Care, and Independent Living. Through third-party management contracts, Civitas provides expert management services for operational start-ups, turn-around operations, and on-going operations. Civitas Senior Living works closely with developers to optimize operations through developing partnerships that align interests. When contracting with Civitas Senior Living, you are partnering with an experienced operator that is also an owner. This ownership experience provides a proven track record of operating properties with excellent financial returns and high occupancy rates while focusing on customer satisfaction.
Carrot is a complete global fertility solution for today`s modern employers and payers, providing flexible financial coverage and expert care navigation across the U.S. and 50+ countries. Get a quick demo and briefing about how modern companies are using Carrot to drive down healthcare costs, attract and retain top talent, and build cultures of inclusion.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.